[1] 中华医学会.病毒性肝炎防治方案[J].中华内科杂志, 2001, 40∶62-68.
|
[2] Solerio E, Isaia G, Innarella R, et al.Osteoporosis:still a typ icalcomplication of primary b iliary cirrhosis?[J].D ig L iver D is, 2003, 35∶39-46.
|
[3] Santolaria F, Gonzalez Reim ers E, Perez Manzano Jl, et al.Os-teopen ia assessed by body composition analysis is related to malnutri-tion in alcoholic patients[J].A lcohol, 2000, 22∶147-57.
|
[4] Bonde M, Qvist P, Fledelius C, et al.Immunoassay for quantifyingtypy 1 collagen degradation products in ru ine evaluated[J].C linChem, 1994, 40∶2022-2025.
|
[5] 郭世绂, 罗先正, 邱贵兴.骨质疏松基础与临床[M].天津:津科学技术出版社, 2001∶127-143.
|
[6] Mark C, Horow it Z.Cytok ines and estrogen in bone:anti-osteo-protic effects[J].S icience, 1993, 260∶626-627.
|
[7] Burgess T, Q ian Y, Kaufman S, et al.The ligand for osteoprotegerin (OPGL) d irectly activates mature osteoclasts[J].Cell B iol, 1999, 145∶527-38.
|
[8]孙永良, 张立煌, 方海林, 等.病毒性肝炎患者IL-1、IL-6、TNF-α活性的检测[J].中华微生物和免疫学杂志, 1994, 14∶187-189.
|